Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
MBIO Mustang Bio Inc
- Stocks
- Healthcare
- NASDAQ: MBIO
Price (delayed)
$1.29
Market cap
$5.65M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$27.12
Enterprise value
-$8.58M
Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare
Highlights
MBIO's equity has surged by 193% since the previous quarter and by 173% year-on-year
The quick ratio has soared by 175% YoY and by 132% QoQ
Key stats
What are the main financial stats of MBIO
Market
Valuations
Earnings
Shares outstanding
4.38M
Market cap
$5.65M
Enterprise value
-$8.58M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.18
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$11.27M
Net income
-$10.71M
EBIT
-$10.71M
EBITDA
-$10.54M
Free cash flow
-$6.31M
Per share
Balance sheet
Liquidity
EPS
-$27.12
EPS diluted
-$27.12
Free cash flow per share
-$2.21
Book value per share
$1.09
Revenue per share
$0
TBVPS
$5.21
Total assets
$14.91M
Total liabilities
$11.3M
Debt
$0
Equity
$3.61M
Working capital
$3.76M
Debt to equity
0
Current ratio
1.34
Quick ratio
1.32
Net debt/EBITDA
1.35
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-107.3%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-284.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MBIO stock price
How has the Mustang Bio stock price performed over time
Intraday
0%
1 week
0.78%
1 month
18.35%
1 year
-86.19%
YTD
-85.42%
QTD
3.2%
Financial performance
How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.27M
Net income
-$10.71M
Gross margin
N/A
Net margin
N/A
MBIO's net income has surged by 73% year-on-year and by 32% since the previous quarter
MBIO's operating income has soared by 70% YoY and by 31% from the previous quarter
Price vs fundamentals
How does MBIO's price correlate with its fundamentals
Growth
What is Mustang Bio's growth rate over time
Valuation
What is Mustang Bio stock price valuation
P/E
N/A
P/B
1.18
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MBIO's EPS has surged by 88% year-on-year and by 30% since the previous quarter
MBIO's equity has surged by 193% since the previous quarter and by 173% year-on-year
The P/B is 85% below the 5-year quarterly average of 8.1
Efficiency
How efficient is Mustang Bio business performance
MBIO's ROA is up by 45% YoY and by 33% from the previous quarter
Dividends
What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MBIO.
Financial health
How did Mustang Bio financials performed over time
Mustang Bio's total assets is 32% more than its total liabilities
The quick ratio has soared by 175% YoY and by 132% QoQ
Mustang Bio's current ratio has surged by 153% YoY and by 97% QoQ
The company's debt is 100% lower than its equity
MBIO's equity has surged by 193% since the previous quarter and by 173% year-on-year
The debt to equity has soared by 100% QoQ and by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.